Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Disc Medicine, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +6 vs. Q4 2024
- Shares held
- 33.2M
- +6.63M (+25.0%) vs. Q4 2024
- Total value
- $1.65B
- −$31.7M (−1.9%) vs. Q4 2024
- New holders
- 27
- 74 more added
- Sold out
- 21
- 31 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $3.13B |
| Q1 2026 | 203 | $2.67B |
| Q4 2025 | 197 | $3.04B |
| Q3 2025 | 168 | $2.26B |
| Q2 2025 | 152 | $1.80B |
| Q1 2025 | 157 | $1.65B |
| Q4 2024 | 152 | $1.68B |
| Q3 2024 | 132 | $1.35B |
| Q2 2024 | 121 | $1.24B |
| Q1 2024 | 130 | $1.38B |
| Q4 2023 | 112 | $1.17B |
| Q3 2023 | 91 | $934.0M |
| Q2 2023 | 90 | $848.7M |
| Q1 2023 | 45 | $309.6M |
| Q4 2022 | 35 | $215.8M |
| Q3 2022 | 44 | $43.9M |
| Q2 2022 | 51 | $43.8M |
| Q1 2022 | 57 | $39.6M |
| Q4 2021 | 62 | $93.8M |
| Q3 2021 | 62 | $103.5M |
| Q2 2021 | 55 | $165.3M |
| Q1 2021 | 49 | $346.6M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Disc Medicine, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 53,808 | $2.67M | 0.00% | +18,463+52.2% | Added |
| Exome Asset Management LLC | 61,656 | $3.06M | 2.74% | −7,416−10.7% | Reduced |
| Citadel Advisors LLC | 62,214 | $3.09M | 0.00% | −529,057−89.5% | Reduced |
| Bank of New York Mellon Corp | 63,503 | $3.15M | 0.00% | +6,242+10.9% | Added |
| Ameriprise Financial Inc | 67,905 | $3.37M | 0.00% | +62,627+1,186.6% | Added |
| Susquehanna International Group, LLP | 70,941 | $3.52M | 0.01% | +42,134+146.3% | Added |
| Ensign Peak Advisors, Inc | 72,513 | $3.60M | 0.01% | +32,513+81.3% | Added |
| UBS Group AG | 72,628 | $3.61M | 0.00% | +48,286+198.4% | Added |
| Sio Capital Management, LLC | 73,511 | $3.65M | 1.11% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 77,050 | $3.82M | 0.04% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 80,000 | $3.97M | 0.16% | +80,000 | New |
| Patient Square Capital LP | 83,000 | $4.12M | 1.70% | +26,600+47.2% | Added |
| Raymond James Financial Inc | 83,276 | $4.13M | 0.00% | −4,726−5.4% | Reduced |
| Opaleye Management Inc. | 85,000 | $4.22M | 0.94% | +85,000 | New |
| Schroder Investment Management Group | 87,290 | $4.57M | 0.00% | −4,200−4.6% | Reduced |
| UBS Asset Management Americas Inc | 96,557 | $4.79M | 0.00% | +3,454+3.7% | Added |
| Millennium Management LLC | 108,499 | $5.39M | 0.01% | +100,620+1,277.1% | Added |
| Nuveen, LLC | 112,717 | $5.60M | 0.00% | +112,717 | New |
| Pictet Asset Management Holding SA | 130,386 | $6.47M | 0.01% | +904+0.7% | Added |
| Goldman Sachs Group Inc | 130,751 | $6.49M | 0.00% | −41,059−23.9% | Reduced |
| Dimensional Fund Advisors LP | 139,393 | $6.92M | 0.00% | −327−0.2% | Reduced |
| Blue Owl Capital Holdings LP | 140,260 | $6.96M | 2.25% | +20,000+16.6% | Added |
| Nantahala Capital Management, LLC | 148,391 | $7.37M | 0.61% | −1,609−1.1% | Reduced |
| Perceptive Advisors LLC | 150,000 | $7.45M | 0.26% | +150,000 | New |
| Morgan Stanley | 170,210 | $8.45M | 0.00% | +20,186+13.5% | Added |
| Eventide Asset Management, LLC | 181,818 | $9.03M | 0.18% | +181,818 | New |
| Renaissance Technologies LLC | 191,220 | $9.49M | 0.01% | +104,800+121.3% | Added |
| Victory Capital Management Inc | 193,664 | $9.61M | 0.01% | −42,580−18.0% | Reduced |
| Charles Schwab Investment Management Inc | 194,725 | $9.67M | 0.00% | +29,653+18.0% | Added |
| Northern Trust Corp | 208,813 | $10.4M | 0.00% | +21,796+11.7% | Added |
| D. E. Shaw & Co., Inc. | 219,603 | $10.9M | 0.01% | +138,413+170.5% | Added |
| Silverarc Capital Management, LLC | 236,471 | $11.7M | 2.45% | +126,090+114.2% | Added |
| Checkpoint Capital L.P. | 243,311 | $12.1M | 6.63% | +58,311+31.5% | Added |
| Foresite Capital Management V, LLC | 299,069 | $14.8M | 16.94% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 300,000 | $14.9M | 0.03% | −50,000−14.3% | Reduced |
| Logos Global Management LP | 394,342 | $19.6M | 3.48% | +194,342+97.2% | Added |
| Armistice Capital, LLC | 436,000 | $21.6M | 0.58% | +80,000+22.5% | Added |
| TCG Crossover Management, LLC | 465,257 | $23.1M | 3.15% | −21,700−4.5% | Reduced |
| Woodline Partners LP | 502,230 | $24.9M | 0.16% | +105,630+26.6% | Added |
| Saturn V Capital Management LLC | 518,177 | $25.7M | 12.98% | +8,771+1.7% | Added |
| Geode Capital Management, LLC | 571,984 | $28.4M | 0.00% | +99,278+21.0% | Added |
| JPMorgan Chase & Co | 759,338 | $37.7M | 0.00% | +698,321+1,144.5% | Added |
| Deerfield Management Company, L.P. (Series C) | 782,333 | $38.8M | 0.77% | +181,818+30.3% | Added |
| State Street Corp | 918,567 | $45.6M | 0.00% | +149,832+19.5% | Added |
| Bain Capital Life Sciences Investors, LLC | 983,500 | $48.8M | 7.22% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,071,865 | $53.2M | 3.00% | +1,071,865 | New |
| Paradigm Biocapital Advisors LP | 1,210,971 | $60.1M | 2.77% | −286,749−19.1% | Reduced |
| Vanguard Group Inc | 1,305,046 | $64.8M | 0.00% | +236,800+22.2% | Added |
| Price T Rowe Associates Inc | 1,358,254 | $67.4M | 0.01% | −36,383−2.6% | Reduced |
| OrbiMed Advisors LLC | 1,415,020 | $70.2M | 1.69% | −370,551−20.8% | Reduced |
| Janus Henderson Group PLC | 1,423,259 | $74.5M | 0.04% | +205,444+16.9% | Added |
| Ra Capital Management, L.P. | 1,577,106 | $78.3M | 1.31% | +1,577,106 | New |
| Frazier Life Sciences Management, L.P. | 1,754,834 | $87.1M | 3.98% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,094,560 | $104.0M | 0.00% | +234,828+12.6% | Added |
| Wellington Management Group LLP | 2,343,499 | $116.3M | 0.02% | +948,094+67.9% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,384,456 | $118.4M | 22.69% | −125,000−5.0% | Reduced |
| FMR LLC | 3,224,381 | $160.1M | 0.01% | +1,358,133+72.8% | Added |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −346,401−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −179,815−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −25,778−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,203−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,187−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −13,444−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,353−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −11,775−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,507−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,358−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −7,667−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −6,213−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −4,875−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −4,497−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −4,196−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,176−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −1,106−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |